Celestra Inc. (KOSDAQ: A352770)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
Celestra Inc. (KOSDAQ: A352770) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.28M.
trading between 4.24K and 33.97K.
Tweenvest scores Celestra Inc. across four factors: quality 24/100, value 60/100. Its strongest factor is value.
A352770 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.28M
- Revenue (TTM)
- $-102.22K
- P/E
- —
- EPS
- -2,293.31
- Dividend yield
- —
- Beta (5Y)
- 0.83
- 52-week high
- ₩33,975.00
- 52-week low
- ₩4,245.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.56M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| AtonENXTPA: ALTAO | $9.46M | €0.01 | -5.56% |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
| Cambium Bio LimitedASX: CMB | $9.22M | AU$0.45 | -16.67% |
| Spago Nanomedical AB (publ)OM: SPAGO | $9.19M | Skr0.11 | +12.32% |
| BioVie Inc.NasdaqCM: BIVI | $9.05M | $1.20 | -13.67% |
| Hemostemix Inc.TSXV: HEM | $8.97M | CA$0.06 | -20.00% |
Figures last refreshed Oct 18, 2026.